<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37258043</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2056-5933</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>RMD open</Title><ISOAbbreviation>RMD Open</ISOAbbreviation></Journal><ArticleTitle>Genetic dissection of <i>HLA-DRB1*15:01</i> and XL9 region variants in Japanese patients with systemic lupus erythematosus: primary role for <i>HLA-DRB1*15:01</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003214</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2023-003214</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Major histocompatibility complex strongly contributes to susceptibility to systemic lupus erythematosus (SLE). In the European populations, <i>HLA-DRB1*03:01</i> and <i>DRB1*15:01</i> are susceptibility alleles, but <i>C4</i> locus was reported to account for the association of <i>DRB1*03:01</i>. With respect to <i>DRB1*15:01</i>, strong linkage disequilibrium with a variant rs2105898T in the XL9 region, located between <i>DRB1</i> and <i>DQA1</i> and regulates HLA-class II expression levels, was reported; however, the causative allele remains to be determined. Leveraging the genetic background of the Japanese population, where <i>DRB1*15:01</i> and <i>DRB1*15:02</i> are commonly present and only <i>DRB1*15:01</i> is associated with SLE, this study aimed to distinguish the genetic contribution of <i>DRB1*15:01</i> and XL9 variants.</AbstractText><AbstractText Label="METHODS">Among the XL9 variants, two (rs2105898 and rs9271593) previously associated variants in the European populations and two (rs9271375 and rs9271378) which showed a trend towards association in a Japanese Genome-Wide Association Study were selected. Associations of the XL9 variants and <i>HLA-DRB1</i> were examined in 442 Japanese SLE patients and 779 controls. Genotyping of the XL9 variants was performed by TaqMan SNP Genotyping Assay and direct sequencing. <i>HLA-DRB1</i> alleles were determined by PCR-reverse sequence-specific oligonucleotide probes.</AbstractText><AbstractText Label="RESULTS">Among the XL9 variants, associations of rs2105898T and rs9271593C were replicated in the Japanese population. However, these associations became no longer significant when conditioned on <i>DRB1*15:01</i>. In contrast, the association of <i>DRB1*15:01</i> remained significant after conditioning on the XL9 variants.</AbstractText><AbstractText Label="CONCLUSION">In the Japanese population, <i>HLA-DRB1*15:01</i> was found to be primarily associated with SLE, and to account for the apparent association of XL9 region.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kawasaki</LastName><ForeName>Aya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5142-5610</Identifier><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Institute of Medicine, University of Tsukuba, Tsukuba, Japan tsuchiya.nyk@gmail.com a-kawasaki@md.tsukuba.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medical Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusumawati</LastName><ForeName>Premita Ari</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawamura</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medical Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusaoi</LastName><ForeName>Makio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0064-4765</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Faculty of Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amano</LastName><ForeName>Hirofumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Faculty of Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Juntendo University Nerima Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusanagi</LastName><ForeName>Yasuyoshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itoh</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4122-2983</Identifier><AffiliationInfo><Affiliation>Division of Hematology and Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimoto</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Nara Medical University, Kashihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamura</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1729-2954</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Rheumatology, Faculty of Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Isao</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumida</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuchiya</LastName><ForeName>Naoyuki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6776-5580</Identifier><AffiliationInfo><Affiliation>Molecular and Genetic Epidemiology Laboratory, Institute of Medicine, University of Tsukuba, Tsukuba, Japan tsuchiya.nyk@gmail.com a-kawasaki@md.tsukuba.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master's Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medical Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>RMD Open</MedlineTA><NlmUniqueID>101662038</NlmUniqueID><ISSNLinking>2056-5933</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489631">HLA-DRB1*15:01 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">polymorphism, genetic</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Competing interests: AK has received research grants from Ichiro Kanehara Foundation, Takeda Science Foundation, and Japan College of Rheumatology, and honoraria for lectures from Chugai Pharmaceutical. YKo has received a research grant from GlaxoSmithKline Japan, and honoraria for lectures from GlaxoSmithKline Japan, AstraZeneca and Asahi Kasei Pharma. HA has received consulting fee from Nippon Shinyaku, honoraria for lectures and support for attending meetings and/or travel from Janssen Pharmaceutical, Eli Lilly Japan, Taisho Pharmaceutical, Nippon Boehringer Ingelheim, Eisai, Mitsubishi Tanabe Pharma, Nippon Shinyaku, Chugai Pharmaceutical, Glaxo Smith Kline Pharmaceuticals, Ono Pharmaceutical, Asahi Kasei Pharma, Astra Zeneca, AbbVie and Ayumi Pharmaceutical. NTa has received grants from Asahi Kasei Pharma, Asahi Kasei Medical, Ayumi, AbbVie, Eisai, Nippon Boehringer Ingelheim, Taisho, Tanabe Mitsubishi, and Chugai, and honoraria for lectures from Asahi Kasei Pharma, AstraZeneca, AbbVie, Eli Lilly Japan, GlaxoSmithKline, Chugai, Novartis, Bristol-Myers Squibb, and Janssen. KI and YKu have received grants from Asahi Kasei Pharma, Eizai, Teijin Pharma, and Chugai Pharmaceutical. KI has received honoraria for lectures from Asahi Kasei Pharma and AbbVie. NTs has received grants from Bristol-Myers Squibb K.K., the Naito Foundation, the Uehara Memorial Foundation, and collaborative research fund from H.U. Group Research Institute G.K. NTs has received award grants from Japan College of Rheumatology and Japan Rheumatism Foundation, and honoraria for lectures from Teijin</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37258043</ArticleId><ArticleId IdType="pmc">PMC10255040</ArticleId><ArticleId IdType="doi">10.1136/rmdopen-2023-003214</ArticleId><ArticleId IdType="pii">rmdopen-2023-003214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ha E, Bae SC, Kim K. Recent advances in understanding the genetic basis of systemic lupus erythematosus. Semin Immunopathol 2022;44:29&#x2013;46. 10.1007/s00281-021-00900-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-021-00900-w</ArticleId><ArticleId IdType="pubmed">34731289</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, et al. . Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 2017;8:16021. 10.1038/ncomms16021</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Kim K, Suetsugu H, et al. . Meta-analysis of 208370 East Asians identifies 113 susceptibility Loci for systemic lupus erythematosus. Ann Rheum Dis 2021;80:632&#x2013;40. 10.1136/annrheumdis-2020-219209</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219209</ArticleId><ArticleId IdType="pmc">PMC8053352</ArticleId><ArticleId IdType="pubmed">33272962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Molineros JE, Looger LL, et al. . High-density genotyping of immune-related Loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet 2016;48:323&#x2013;30. 10.1038/ng.3496</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3496</ArticleId><ArticleId IdType="pmc">PMC4767573</ArticleId><ArticleId IdType="pubmed">26808113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Ma J, Deng Y, et al. . A Missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet 2017;49:433&#x2013;7. 10.1038/ng.3782</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3782</ArticleId><ArticleId IdType="pmc">PMC5400098</ArticleId><ArticleId IdType="pubmed">28135245</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson LM, Johansson &#xc5;C, Gullstrand B, et al. . A single nucleotide polymorphism in the NCF1 Gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis 2017;76:1607&#x2013;13. 10.1136/annrheumdis-2017-211287</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-211287</ArticleId><ArticleId IdType="pubmed">28606963</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama N, Kawasaki A, Matsushita T, et al. . Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population. Sci Rep 2019;9:16366. 10.1038/s41598-019-52920-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52920-0</ArticleId><ArticleId IdType="pmc">PMC6842004</ArticleId><ArticleId IdType="pubmed">31705128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando MMA, Stevens CR, Sabeti PC, et al. . Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007;3:e192. 10.1371/journal.pgen.0030192</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030192</ArticleId><ArticleId IdType="pmc">PMC2065882</ArticleId><ArticleId IdType="pubmed">17997607</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Taylor KE, Fernando MMA, et al. . Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA Alleles and non-HLA genes in Europeans. Am J Hum Genet 2012;91:778&#x2013;93. 10.1016/j.ajhg.2012.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.08.026</ArticleId><ArticleId IdType="pmc">PMC3487133</ArticleId><ArticleId IdType="pubmed">23084292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard CJ, Sajuthi S, Zhao J, et al. . Identification of a systemic lupus erythematosus risk locus spanning ATG16L2, FCHSD2, AND P2RY2 in Koreans. Arthritis Rheumatol 2016;68:1197&#x2013;209. 10.1002/art.39548</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39548</ArticleId><ArticleId IdType="pmc">PMC4981330</ArticleId><ArticleId IdType="pubmed">26663301</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa H, Kawasaki A, Oka S, et al. . Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles Drb1*13:02 and *14:03. PLoS One 2014;9:e87792. 10.1371/journal.pone.0087792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087792</ArticleId><ArticleId IdType="pmc">PMC3912000</ArticleId><ArticleId IdType="pubmed">24498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Morris DL, Noble JA, et al. . Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet 2018;27:3813&#x2013;24. 10.1093/hmg/ddy280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy280</ArticleId><ArticleId IdType="pmc">PMC6196648</ArticleId><ArticleId IdType="pubmed">30085094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirikong M, Tsuchiya N, Chandanayingyong D, et al. . Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 2002;59:113&#x2013;7. 10.1034/j.1399-0039.2002.590206.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0039.2002.590206.x</ArticleId><ArticleId IdType="pubmed">12028537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu LY, Ding WZ, Fici D, et al. . Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138&#x2013;45. 10.1002/art.1780400619</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400619</ArticleId><ArticleId IdType="pubmed">9182925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitaki N, Sekar A, Handsaker RE, et al. . Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 2020;582:577&#x2013;81. 10.1038/s41586-020-2277-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2277-x</ArticleId><ArticleId IdType="pmc">PMC7319891</ArticleId><ArticleId IdType="pubmed">32499649</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyse TJ, Tsao BP. Complement C4, the major histocompatibility complex, and autoimmunity. Arthritis Rheumatol 2022;74:1318&#x2013;20. 10.1002/art.42119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42119</ArticleId><ArticleId IdType="pubmed">35315246</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj P, Rai E, Song R, et al. . Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife 2016;5:e12089. 10.7554/eLife.12089</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.12089</ArticleId><ArticleId IdType="pmc">PMC4811771</ArticleId><ArticleId IdType="pubmed">26880555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaue S, Kanai M, Tanigawa Y, et al. . A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 2021;53:1415&#x2013;24. 10.1038/s41588-021-00931-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00931-x</ArticleId><ArticleId IdType="pubmed">34594039</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham F, Allen JE, Allen J, et al. . Ensembl 2022. Nucleic Acids Res 2022;50:D988&#x2013;95. 10.1093/nar/gkab1049</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1049</ArticleId><ArticleId IdType="pmc">PMC8728283</ArticleId><ArticleId IdType="pubmed">34791404</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder P, Gomez JA, Boss JM. The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF-binding enhancer-blocking element. J Biol Chem 2006;281:18435&#x2013;43. 10.1074/jbc.M601298200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M601298200</ArticleId><ArticleId IdType="pubmed">16675454</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder P, Gomez JA, Chadwick BP, et al. . The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions. J Exp Med 2008;205:785&#x2013;98. 10.1084/jem.20071843</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071843</ArticleId><ArticleId IdType="pmc">PMC2292219</ArticleId><ArticleId IdType="pubmed">18347100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapin N, Hoof I, Lund O, et al. . MHC motif viewer. Immunogenetics 2008;60:759&#x2013;65. 10.1007/s00251-008-0330-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-008-0330-2</ArticleId><ArticleId IdType="pmc">PMC2613509</ArticleId><ArticleId IdType="pubmed">18766337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki K, Lagattuta KA, Luo Y, et al. . HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors. Nat Genet 2022;54:393&#x2013;402. 10.1038/s41588-022-01032-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01032-z</ArticleId><ArticleId IdType="pmc">PMC9010379</ArticleId><ArticleId IdType="pubmed">35332318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kular L, Liu Y, Ruhrmann S, et al. . DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. Nat Commun 2018;9:2397. 10.1038/s41467-018-04732-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04732-5</ArticleId><ArticleId IdType="pmc">PMC6008330</ArticleId><ArticleId IdType="pubmed">29921915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-F, Zhang Y, Lin Z, et al. . Identification of 38 novel Loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun 2021;12:772. 10.1038/s41467-021-21049-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21049-y</ArticleId><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>